Back to homepage

Generating improvement in spinal cord injuries

The use of oligodendrocyte progenitor cells to treat spinal cord injuries has shown promising results in early clinical trials at Rush University Medical Center in the USA, offering new hope


New beds at RNOH spinal cord injury centre will significantly reduce waiting times

Construction has begun on the expansion of the Royal National Orthopaedic Hospital’s London Spinal Cord Injury Centre in Stanmore The service run by the Royal National Orthopaedic Hospital (RNOH) is


Whiplash prognosis: what is the role of pathology?

Physiotherapist Chris Worsfold talks to Spinal Surgery News about identifying and managing risk factors for poor recovery following whiplash injury There are scores of animal, human cadaver and computer simulation


Anterior vertebral body tethering: a promising non-fusion scoliosis treatment

Ahmet Alanay, Caglar Yilgor, Gokhan Ergene, Nuray Sogunmez and Barbaros Omer Cebeci discuss an alternative to bracing and fusion for the treatment of progressive scoliosis. The current standard of care


Philips announces new augmented-reality surgical navigation technology designed for image-guided spine, cranial and trauma surgery

Royal Philips, a provider in integrated image-guided therapy solutions, has announced the development of an industry-first augmented-reality surgical navigation technology that is designed to help surgeons perform image-guided open and minimally-invasive


SIRAKOSS granted two patents for bone graft technologies

SIRAKOSS Ltd, a medical device company based in Aberdeen, has announced that the US Patent and Trademark Office (USPTO) has granted two patents for its bone graft technologies. The company’s


ReproBone® fusion – Injectable multiphasic matrix for bone regeneration

ReproBone® is an advanced range of UK manufactured synthetic and resorbable bone grafts that stimulate, integrate and regenerate natural bone. These biomimetic materials act as ideal scaffolds to support bone


WWII chemical-weapon antidote shows promise to treat spinal cord injuries

A drug developed during World War II as an antidote for a chemical warfare agent has been found to be effective at suppressing a neurotoxin that worsens the pain and


PREVIEW: Global Spine Congress 2017, 3–6 May 2017, Milan

The AOSpine annual flagship event this year takes place in Italy at the Milan Congress Center The Global Spine Congress (GSC) has a packed schedule this year with a unique


Money Matters – Time is running out. Simon Bruce on why you need to protect your pension now

MONEY MATTERS You have just a few more months to apply for a government scheme which can protect the value of your pension from substantial tax charges. And, to give